Skip to main content
Premium Trial:

Request an Annual Quote

Bulgarian Center to Use IBM Supercomputer for Genomics and Drug Studies

NEW YORK (GenomeWeb News) – Bulgaria has installed a new IBM Blue Gene/P supercomputer, which it plans to use for genomics, proteomics, and drug studies, as well as for other purposes such as financial modeling, at the Bulgarian State Agency for Information Technology in Sofia.
 
The Bulgarian National Centre for Human Genomics and Proteomics will use the Blue Gene/P to run algorithms to isolate key genes and drug targets in common diseases. Researchers plan to analyze the function of population-validated disease genes and the proteins they encode in studies of biological pathways of diseases.
 
Bulgaria also will use the computer to simulate drug development and to filter through sequencing data from the human genome.
 
"This agreement with IBM begins a new era of supercomputing in Bulgaria and creates huge potential to boost scientific research in the region as a whole," Plamen Vachkov, chairman of the Bulgarian State Agency for Information Technology and Communications, said in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.